Blood Pressure Management in Patients with Acute Ischemic Stroke

Hypertension

Volumn 43, Issue 2 I, 2004, Pages 137-141

  Goldstein, Larry B ^a,b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LABETALOL; NICARDIPINE; NITROPRUSSIDE SODIUM; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE DISEASE; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; AUTOREGULATION; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BRAIN BLOOD FLOW; CASE REPORT; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIASTOLIC BLOOD PRESSURE; DRUG CHOICE; DRUG INDICATION; HUMAN; HYPERTENSION; LABORATORY TEST; MALE; MEAN ARTERIAL PRESSURE; MEDICAL DECISION MAKING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT COMPLIANCE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TREATMENT PLANNING;

ACUTE DISEASE; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; HUMANS; MALE;

EID: 0842332597     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000113297.76013.51     Document Type: Article

References (52)

1. Adams HP, Adams RJ, Brott T, del Zoppo GJ, Furlan A, Goldstein LB, Grubb RL, Higashida R, Kidwell C, Kwiatowski TG, Hademenos GJ. Guidelines for the early management of patients with ischemic stroke: A Scientific Statement from the Stroke Council of the Am Stroke Association. Stroke. 2003;34:1056-1083.
2. Moulin T, Cattin F, Crepin-Leblond T, Tatu L, Chavot D, Piotin M, Viel JF, Rumbach L, Bonneville JF. Early CT signs in acute middle cerebral artery infarction: Predictive value for subsequent infarct locations and outcome. Neurology. 1996;47:366-375.
3. Fisher CM. Facial pulses in internal carotid artery occlusion. Neurology. 1979;20:476-478.
4. Goldstein LB. Symptoms, signs, differential diagnosis, and medical assessment of patients with carotid disease. In: Bederson JB, Tuhrim S, eds. Treatment of Carotid Disease: A Practitioner's Manual. Park Ridge, IL: Am Association of Neurological Surgeons; 1998:45-61.
5. Rodgers A, MacMahon S, Gamble G, Slattery J, Sandercock P, Warlow C. Blood pressure and risk of stroke in patients with cerebrovascular disease. BMJ. 1996;313:147.
6. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation study investigators. N Engl J Med. 2000;342:145-153.
7. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033-1041.
8. Marler JR, Brott T, Broderick J, Kothari R, O'Donoghue M, Barsan W, Tomsick T, Spilker J, Miller R, Sauerbeck L, Jarrell J, Kelly J, Perkins T, McDonald T, Rorick M, Hickey C, Armitage J, Perry C, Thalinger K, Rhude R, Schill J, Becker PS, Heath RS, Adams D. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
9. Kwiatkowski TG, Libman RB, Frankel M, Tilley BC, Morgenstern LB, Lu M, Broderick JP, Lewandowski CA, Marler JR, Levine SR, Brott T. Effects of tissue plasminogen activator for acute ischemic stroke at one year. N Engl J Med. 1999;340:1781-1787.
10. Strandgaard S, Olesen J, Skinhoj E, Lassen NA. Autoregulation of brain circulation in severe arterial hypertension. BMJ. 1973;1:507-510.
11. Powers WJ. Acute hypertension after stroke: The scientific basis for treatment decisions. Neurology. 1993;43:461-467.
12. Meyer JS, Shimazu K, Fukuuchi Y, Ohuchi T, Okamoto S, Koto A, Ericsson AD. Impaired neurogenic cerebrovascular control and dysautoregulation after stroke. Stroke. 1973;4:169-186.
13. Pannier JL, Weyne J, Leusen I. Effects of changes in acid-base composition in the cerebral ventricles on local and general cerebral blood flow. Eur Neurol. 1971;6:123-126.
14. Lisk DR, Grotta JC, Lamki LM, Tran HD, Taylor JW, Molony DA, Barron BJ. Should hypertension be treated after acute stroke? A randomized controlled trial using single photon emission computed tomography. Arch Neurol. 1993;50:855-862.
15. Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischemia - the ischemic penumbra. Stroke. 1981;12:723-725.
16. Hossmann K-A. Viability thresholds and the penumbra of focal ischemia. Ann Neurol. 1994:36:557-565.
17. Ginsberg MD, Belayev L, Zhao W. Recruitment of the ischemic penumbra into the necrotic core. Cerebrovasc Dis. 1997;7:14-18.
18. Ginsberg MD. Injury mechanisms in the ischaemic penumbra - Approaches to neuroprotection in acute ischaemic stroke. Cerebrovasc Dis. 1997;7:7-12.
19. Heiss W-D, Huber M, Fink GR, Herholz K, Pietrzyk U, Wagner R, Wienhard K. Progressive derangement of periinfarct viable tissue in ischemic stroke. J Cereb Blood Flow Metab. 1992;12:193-203.
20. Furlan M, Marchal G, Viader F, Derlon JM, Baron JC. Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra. Ann Neurol. 1996;40:216-226.
21. Baron J-C. Mapping the ischaemic penumbra with PET: implications for acute stroke treatment. Cerebrovasc Dis. 1999;9:193-201.
22. Latchaw RE, Yonas H, Hunter GJ, Yuh WTC, Ueda T, Sorensen AG, Sunshine JL, Biller J, Wechsler L, Higashida R, Hademenos G. Guidelines and recommendations for perfusion imaging in cerebral ischemia - A scientific statement for healthcare professionals by the Writing Group on Perfusion Imaging, from the Council on Cardiovascular Radiology of the Am Heart Association. Stroke. 2003;34:1084-1104.
23. Parsons MW, Barber PA, Chalk J, Darby DG, Rose S, Desmond PM, Gerraty RP, Tress BM, Wright PM, Donnan GA, Davis SM. Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke. Ann Neurol. 2002;51:28-37.
24. Jansen O, Schellinger P, Fiebach J, Hacke W, Sartor K. Early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRI. Lancet. 1999;353:2036-2037.
25. Kidwell CS, Saver JL, Mattiello J, Starkman S, Vinuela F, Duckwiler G, Gobin YP, Jahan R, Vespa P, Kalafut M, Alger JR. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol. 2000;47:462-469.
26. Klotz E, Konig M. Perfusion measurements of the brain: using dynamic CT for the quantitative assessment of cerebral ischemia in acute stroke. Eur J Radiol. 1999;30:170-184.
27. Lev MH, Segal AZ, Farkas J, Hossain ST, Putman C, Hunter GJ, Budzik R, Harris GJ, Buonanno FS, Ezzeddine MA, Chang YC, Koroshetz WJ, Gonzalez RG, Schwamm LH. Utility of perfusion-weighted CT imaging in acute middle cerebral artery stroke treated with intra-arterial thrombolysis. Prediction of final infarct volume and clinical outcome. Stroke. 2001;32:2021-2027.
28. Baumbach GL, Heistad DD. Cerebral circulation in chronic arterial hypertension. Hypertension. 1998;12:89-95.
29. Kwa VIH, Van der Sande JJ, Stam J, Tijmes N, Vrooland JL. Retinal arterial changes correlate with cerebral small-vessel disease. Neurology. 2002;59:1536-1540.
30. Heyman A, Wilkinson WE, Heyden S, Helms MJ, Bartel AG, Karp HR, Tyroller HA, Hames CG. Risk of stroke in asymptomatic persons with cervical arterial bruits. N Engl J Med. 1980;302:838-841.
31. Wolf PA, Kannel WB, Sorlie P, McNamara P. Asymptomatic carotid bruit and risk of stroke. The Framingham study. JAMA. 1981;245:1442-1445.
32. Ziegler DK, Zileli T, Dick A, Sebaugh JL. Correlation of bruits over the carotid artery with angiographically demonstrated lesions. Neurology. 1971;21:860-865.
33. David TE, Humphries AW, Young JR, Beven EG. A correlation of neck bruits and atherosclerotic carotid arteries. Arch Surg. 1973;107:729-731.
34. Britton M, De Faire U, Helmers C. Hazards of therapy for excessive hypertension in acute stroke. Acta Med Scand. 1980;207:253-257.
35. Wallace JD, Levy LL. Blood pressure after stroke. JAMA. 1981;246:2177-2180.
36. Chamorro A, Vila N, Ascaso C, Elices E, Schonewille W, Blanc R. Blood pressure and functional recovery in acute ischemic stroke. Stroke. 1998;29:1850-1853.
37. Harper G, Castleden CM, Potter JF. Factors affecting changes in blood pressure after acute stroke. Stroke. 1994;25:1726-1729.
38. Carlberg B, Asplund K, Hägg R. Course of blood pressure in different subsets of patients after acute stroke. Cerebrovasc Dis. 1991;1:281-287.
39. Phillips SJ. Pathophysiology and management of hypertension in acute ischemic stroke. Hypertension. 1994;23:131-136.
40. Britton M, Carlsson A. Very high blood pressure in acute stroke. J Intern Med. 1990;228:611-615.
41. Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS. Effect of blood pressure and diabetes on stroke in progression. Lancet. 1994;344:156-159.
42. Ahmed N, Wahlgren NG. High initial blood pressure after acute stroke is associated with poor functional outcome. J Intern Med. 2001;249:467-473.
43. Aslanyan S, Fazekas F, Weir CJ, Horner S, Lees KR. Effect of blood pressure during the acute period of ischemic stroke on stroke outcome. Stroke. 2003;34:2420-2425.
44. Kaste M, Fogelholm R, Erilä T, Palomäki H, Murros K, Rissanen A, Sarna S. A randomized, double-blind, placebo-controlled trial of nimodipine in acute ischemic hemispheric stroke. Stroke. 1994;25:1348-1353.
45. Wahlgren NG, MacMahon DG, De Keyser J, Indredavik B, Ryman T. Intravenous Nimodipine West European Stroke Trial (INWEST) of nimodipine in the treatment of acute ischaemic stroke. Cerebrovasc Dis. 1994;4:204-210.
46. Ahmed N, Nasman P, Wahlgren NG. Effect of intravenous nimodipine on blood pressure and outcome after acute stroke. Stroke. 2000;31:1250-1255.
47. Ahmed N, Wahlgren NG. Effects of blood pressure lowering in the acute phase of total anterior circulation infarcts and other stroke subtypes. Cerebrovasc Dis. 2003;15:235-243.
48. Oliveira-Filho J, Silva SCS, Trabuco CC, Pedreira BB, Sousa EU, Bacellar A. Detrimental effect of blood pressure reduction in the first 24 ours of acute stroke onset. Neurology. 2003;61:1047-1051.
49. Brott T, Lu M, Kothari R, Fagan SC, Frankel M, Grotta JC, Broderick J, Kwiatkowski T, Lewandowski C, Haley EC, Marler JR, Tilley BC. Hypertension and its treatment in the NINDS rt-PA Stroke Trial. Stroke. 1998;29:1504-1509.
50. Rordorf G, Cramer SC, Efird JT, Schwamm LH, Buonanno F, Koroshetz WJ. Pharmacological elevation of blood pressure in acute stroke. Clinical effects and safety. Stroke. 1997;28:2133-2138.
51. Schrader J, Luders S, Kulschewski A, Berger JR, Zidek W, Treib J, Einhaupl K, Diener HC, Dominiak P. The ACCESS Study - Evaluation of acute candesartan cilexetil therapy in stroke survivors. Stroke. 2003;34:1699-1703.
52. Cochrane Stroke Group. Vasoactive drugs for acute stroke. Cochrane Database of Systematic Reviews. 2003.